Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CoMentis
This pilot study will be the first time that nicotine will be applied directly onto the surface of chronic diabetic ulcer. The goals of the study are to evaluate safety and tolerability (particularly at the wound site) of a gel formulation containing low-dose nicotine, and to obtain preliminary information on its effects on accelerating wound closure. The study will be carried out on a background of conventional wound therapy in patients with Type II diabetes mellitus. Patients will be randomized to receive either study medication (ATG002), vehicle gel, or standard-of-care.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with diabetes mellitus type II
Single non-healing uninfected partial or full-thickness foot ulcer secondary to diabetic neuropathy, in the absence of significant peripheral arterial disease.
You may not be if
Patients who use tobacco in any form or who are on nicotine replacement therapy